ImmunogenX

ImmunogenX is a company developing a therapy for individuals with celiac disease. It also provides a diagnostic tool using a metabolic marker compound that measures the state of recovery of a celiac patient undergoing gluten-free diet treatment. Additionally, the company is engaged in research focused on gluten toxic peptide epitopes in wheat, barley, and rye.
TypeSubsidiary
Founded2013
Websiteimmunogenx.com
ImmunogenX was founded in 2013

Viewing summary data as a guest

Sign up for free to see all data

ImmunogenX Financials and Metrics

Summary Metrics

Founding Date

2013

ImmunogenX Online and Social Media Presence

Embed Graph

ImmunogenX Frequently Asked Questions

  • When was ImmunogenX founded?

    ImmunogenX was founded in 2013.

  • Who are ImmunogenX competitors?

    Competitors of ImmunogenX include SleepEffect Center for Apnea Management, Stago and Xcelris.